RBC Capital lowered the firm’s price target on Patterson-UTI (PTEN) to $8.50 from $9 and keeps an Outperform rating on the shares. Patterson-UTI’s Q2 results were in-line with estimates as the company focuses on increasing the competitiveness of its offerings through enhanced technology implementation, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTEN:
- Patterson-UTI Energy Reports Q2 2025 Financial Results
- Patterson-UTI Energy Navigates Challenges with Optimism
- Patterson-UTI: Strong Financial Performance and Promising Outlook Support Buy Rating
- Patterson-UTI Reports Q2 2025 Net Loss Amid Impairment
- Patterson-UTI reports Q2 EPS (13c), consensus (4c)